Oncology and Hematology
385-400 of 650
Susana Campos, MD, MPH
Ritu Salani, MD, MBA
- MinuteCE®
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
1.00 program creditNicoletta Colombo, MD
Ritu Salani, MD, MBA
- MinuteCE®
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
1.00 program creditRitu Salani, MD, MBA
Nicoletta Colombo, MD
Ignacio Duran, MD
Wenxin Xu, MD
Ignacio Duran, MD
Sandy Srinivas, MD
Ignacio Duran, MD
Wenxin Xu, MD
Sandy Srinivas, MD
Susana Campos, MD, MPH
Nicoletta Colombo, MD
Ritu Salani, MD, MBA
Susana Campos, MD, MPH
Ritu Salani, MD, MBA
Ignacio Duran, MD
Sandy Srinivas, MD
- MinuteCE®
Emerging targeted therapy combination strategies in genitourinary malignancies
1.25 program creditsIgnacio Duran, MD
Nicoletta Colombo, MD
Constance Lehman, MD, PhD
Wenxin Xu, MD
Sandy Srinivas, MD
- MinuteCE®
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
1.00 program creditRitu Salani, MD, MBA
Nicoletta Colombo, MD
Rachelle W. Johnson, PhD
